Test may offer early detection
A blood test that diagnoses Alzheimer's disease, Parkinson's and other neurodegenerative diseases with over 90% accuracy could be on the market as early as this summer, according to a report from the Society of Chemical Industry. Power3 Medical Products has developed the test to measure the relative levels of 59 different protein biomarkers in the blood. NuroPro, as the test is called, can then distinguish between the different diseases. This would be the first diagnostic test for these types of disorders ever available, according to the firm.